Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

967 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study.
Coulter TI, Chandra A, Bacon CM, Babar J, Curtis J, Screaton N, Goodlad JR, Farmer G, Steele CL, Leahy TR, Doffinger R, Baxendale H, Bernatoniene J, Edgar JD, Longhurst HJ, Ehl S, Speckmann C, Grimbacher B, Sediva A, Milota T, Faust SN, Williams AP, Hayman G, Kucuk ZY, Hague R, French P, Brooker R, Forsyth P, Herriot R, Cancrini C, Palma P, Ariganello P, Conlon N, Feighery C, Gavin PJ, Jones A, Imai K, Ibrahim MA, Markelj G, Abinun M, Rieux-Laucat F, Latour S, Pellier I, Fischer A, Touzot F, Casanova JL, Durandy A, Burns SO, Savic S, Kumararatne DS, Moshous D, Kracker S, Vanhaesebroeck B, Okkenhaug K, Picard C, Nejentsev S, Condliffe AM, Cant AJ. Coulter TI, et al. Among authors: ibrahim ma. J Allergy Clin Immunol. 2017 Feb;139(2):597-606.e4. doi: 10.1016/j.jaci.2016.06.021. Epub 2016 Jul 16. J Allergy Clin Immunol. 2017. PMID: 27555459 Free PMC article.
Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase δ syndrome.
Kracker S, Curtis J, Ibrahim MA, Sediva A, Salisbury J, Campr V, Debré M, Edgar JD, Imai K, Picard C, Casanova JL, Fischer A, Nejentsev S, Durandy A. Kracker S, et al. Among authors: ibrahim ma. J Allergy Clin Immunol. 2014 Jul;134(1):233-6. doi: 10.1016/j.jaci.2014.02.020. Epub 2014 Apr 1. J Allergy Clin Immunol. 2014. PMID: 24698326 Free PMC article. No abstract available.
Novel NFKB2 mutation in early-onset CVID.
Liu Y, Hanson S, Gurugama P, Jones A, Clark B, Ibrahim MA. Liu Y, et al. Among authors: ibrahim ma. J Clin Immunol. 2014 Aug;34(6):686-90. doi: 10.1007/s10875-014-0064-x. Epub 2014 Jun 3. J Clin Immunol. 2014. PMID: 24888602
Anaphylactic shock: the great mimic.
Yong PF, Birns J, Ibrahim MA. Yong PF, et al. Among authors: ibrahim ma. South Med J. 2007 Mar;100(3):295-7. doi: 10.1097/01.smj.0000254171.41354.97. South Med J. 2007. PMID: 17396734
Immunoglobulin replacement therapy: is there a role for IgA and IgM?
Kiani-Alikhan S, Yong PF, Grosse-Kreul D, Elston C, Ibrahim MA. Kiani-Alikhan S, et al. Among authors: ibrahim ma. J Allergy Clin Immunol. 2012 Aug;130(2):553-4; author reply 554. doi: 10.1016/j.jaci.2012.04.032. Epub 2012 Jun 2. J Allergy Clin Immunol. 2012. PMID: 22664164 No abstract available.
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis.
Laing AG, Lorenc A, Del Molino Del Barrio I, Das A, Fish M, Monin L, Muñoz-Ruiz M, McKenzie DR, Hayday TS, Francos-Quijorna I, Kamdar S, Joseph M, Davies D, Davis R, Jennings A, Zlatareva I, Vantourout P, Wu Y, Sofra V, Cano F, Greco M, Theodoridis E, Freedman JD, Gee S, Chan JNE, Ryan S, Bugallo-Blanco E, Peterson P, Kisand K, Haljasmägi L, Chadli L, Moingeon P, Martinez L, Merrick B, Bisnauthsing K, Brooks K, Ibrahim MAA, Mason J, Lopez Gomez F, Babalola K, Abdul-Jawad S, Cason J, Mant C, Seow J, Graham C, Doores KJ, Di Rosa F, Edgeworth J, Shankar-Hari M, Hayday AC. Laing AG, et al. Nat Med. 2020 Dec;26(12):1951. doi: 10.1038/s41591-020-01186-5. Nat Med. 2020. PMID: 33247289 Free PMC article.
967 results